These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34216083)

  • 1. A comparative pilot study of dipstick versus open-spray cryotherapy techniques as depigmentation treatments for vitiligo.
    Abdallah M; Saleh HM
    J Cosmet Dermatol; 2022 Apr; 21(4):1772-1773. PubMed ID: 34216083
    [No Abstract]   [Full Text] [Related]  

  • 2. Site-oriented depigmentation in vitiligo patients using Q-switched Nd:YAG laser (1,064/532 nm), cryotherapy and chemical peels: A comparative study.
    El-Mofty M; Mostafa WZ; Esmat S; Zayed A; Mashaly H; Hussien MF; Ismail SI
    Dermatol Ther; 2019 Sep; 32(5):e13052. PubMed ID: 31376312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laser (755 nm) and cryotherapy as depigmentation treatments for vitiligo: a comparative study.
    van Geel N; Depaepe L; Speeckaert R
    J Eur Acad Dermatol Venereol; 2015 Jun; 29(6):1121-7. PubMed ID: 25286980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depigmentation of the normally pigmented patches in universal vitiligo patients by cryotherapy.
    Radmanesh M
    J Eur Acad Dermatol Venereol; 2000 May; 14(3):149-52. PubMed ID: 11032055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depigmentation therapy in vitiligo universalis with cryotherapy and 4-hydroxyanisole.
    Di Nuzzo S; Masotti A
    Clin Exp Dermatol; 2010 Mar; 35(2):215-6. PubMed ID: 20447090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depigmentation therapies for normal skin in vitiligo universalis.
    AlGhamdi KM; Kumar A
    J Eur Acad Dermatol Venereol; 2011 Jul; 25(7):749-57. PubMed ID: 21054565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depigmentation Therapies for Vitiligo.
    Grimes PE; Nashawati R
    Dermatol Clin; 2017 Apr; 35(2):219-227. PubMed ID: 28317530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repigmentation of poliosis in a patient with segmental vitiligo.
    Bae JM; Kwon HS; Lee JH; Kim GM
    J Am Acad Dermatol; 2016 Jul; 75(1):e23-4. PubMed ID: 27317537
    [No Abstract]   [Full Text] [Related]  

  • 9. Differential diagnosis of idiopathic vitiligo. Part III: Occupational leukoderma.
    Fisher AA
    Cutis; 1994 Jun; 53(6):278-80. PubMed ID: 8070279
    [No Abstract]   [Full Text] [Related]  

  • 10. Depigmentation therapies in vitiligo.
    Gupta D; Kumari R; Thappa DM
    Indian J Dermatol Venereol Leprol; 2012; 78(1):49-58. PubMed ID: 22199060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitiligo and leukoderma in children.
    Herane MI
    Clin Dermatol; 2003; 21(4):283-95. PubMed ID: 14572699
    [No Abstract]   [Full Text] [Related]  

  • 12. Mutant HSP70 reverses autoimmune depigmentation in vitiligo.
    Mosenson JA; Zloza A; Nieland JD; Garrett-Mayer E; Eby JM; Huelsmann EJ; Kumar P; Denman CJ; Lacek AT; Kohlhapp FJ; Alamiri A; Hughes T; Bines SD; Kaufman HL; Overbeck A; Mehrotra S; Hernandez C; Nishimura MI; Guevara-Patino JA; Le Poole IC
    Sci Transl Med; 2013 Feb; 5(174):174ra28. PubMed ID: 23447019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New and experimental treatments of vitiligo and other hypomelanoses.
    Lotti T; Prignano F; Buggiani G
    Dermatol Clin; 2007 Jul; 25(3):393-400, ix. PubMed ID: 17662905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of trichloroacetic acid as a depigmenting therapy in universal vitiligo.
    Nofal A; Fawzy MM; Alakad R
    J Dtsch Dermatol Ges; 2021 Feb; 19(2):241-246. PubMed ID: 33197126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic options and hot topics in vitiligo with special focus on pediatrics' vitiligo: A comprehensive review study.
    Roohaninasab M; Mansouri P; Seirafianpour F; Naeini AJ; Goodarzi A
    Dermatol Ther; 2021 Jan; 34(1):e14550. PubMed ID: 33200859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rational approach to the treatment of vitiligo and other hypomelanoses.
    Hercogová J; Buggiani G; Prignano F; Lotti T
    Dermatol Clin; 2007 Jul; 25(3):383-92, ix. PubMed ID: 17662904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot comparative study of topical latanoprost and tacrolimus in combination with narrow-band ultraviolet B phototherapy and microneedling for the treatment of nonsegmental vitiligo.
    Korobko IV; Lomonosov KM
    Dermatol Ther; 2016 Nov; 29(6):437-441. PubMed ID: 27329330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The color of skin: white diseases of the skin, nails, and mucosa.
    Brown AE; Qiu CC; Drozd B; Sklover LR; Vickers CM; Hsu S
    Clin Dermatol; 2019; 37(5):561-579. PubMed ID: 31896410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excimer light therapy for the treatment of residual depigmentation after at least six months of surgical grafting techniques in stable vitiligo: Results of a retrospective case series.
    Yadav D; Gupta S
    Indian J Dermatol Venereol Leprol; 2022; 88(5):671-674. PubMed ID: 35962519
    [No Abstract]   [Full Text] [Related]  

  • 20. The treatment of hypopigmentation in children.
    Schaffer JV; Bolognia JL
    Clin Dermatol; 2003; 21(4):296-310. PubMed ID: 14572700
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.